BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28633591)

  • 1. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
    Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics.
    Chaudhari P; Ghate VM; Lewis SA
    Eur J Pharm Biopharm; 2021 Apr; 161():80-99. PubMed ID: 33607239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in Topical Ocular Drug Delivery Systems: Hydrogels and Contact Lenses.
    Ribeiro AM; Figueiras A; Veiga F
    J Pharm Pharm Sci; 2015; 18(5):683-95. PubMed ID: 26670365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on therapeutic contact lenses for ocular drug delivery.
    Maulvi FA; Soni TG; Shah DO
    Drug Deliv; 2016 Oct; 23(8):3017-3026. PubMed ID: 26821766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of contact lens based ocular drug delivery systems for single-day use: Part (I) Structural factors, surrogate ophthalmic dyes and passive diffusion studies.
    Mahomed A; Tighe BJ
    J Biomater Appl; 2014 Sep; 29(3):341-53. PubMed ID: 24663443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery.
    Zhu Q; Liu C; Sun Z; Zhang X; Liang N; Mao S
    Eur J Pharm Biopharm; 2018 Jul; 128():220-229. PubMed ID: 29730260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Drug Delivery Systems Using Contact Lenses.
    Novack GD; Barnett M
    J Ocul Pharmacol Ther; 2020 Oct; 36(8):595-601. PubMed ID: 32456518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact lenses as drug reservoirs & delivery systems: the successes & challenges.
    ElShaer A; Ghatora B; Mustafa S; Alany RG
    Ther Deliv; 2014 Oct; 5(10):1085-100. PubMed ID: 25418268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Potential of Nanoporous Materials for Advancing Ophthalmic Treatments.
    Wu KY; Brister D; Bélanger P; Tran SD
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on contact lens for ophthalmic drug delivery.
    Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient loading of ophthalmic drugs with poor loadability into contact lenses using functional comonomers.
    Lee D; Lee N; Kwon I
    Biomater Sci; 2018 Sep; 6(10):2639-2646. PubMed ID: 30117510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' and prescribers' perception of contact lenses as a potential ocular drug delivery system.
    Ghazal H; Ahmadouk J; Dhanji S; El-Bushra A; Kayyali R; ElShaer A
    Cont Lens Anterior Eye; 2019 Apr; 42(2):190-195. PubMed ID: 30442512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.
    Hsu KH; Fentzke RC; Chauhan A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):531-40. PubMed ID: 23665502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart contact lens systems for ocular drug delivery and therapy.
    Kim TY; Lee GH; Mun J; Cheong S; Choi I; Kim H; Hahn SK
    Adv Drug Deliv Rev; 2023 May; 196():114817. PubMed ID: 37004938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.